These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27558175)

  • 1. Investments in tuberculosis research - what are the gaps?
    Khan MS; Fletcher H; ; Coker R
    BMC Med; 2016 Aug; 14(1):123. PubMed ID: 27558175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are scientific research outputs aligned with national policy makers' priorities? A case study of tuberculosis in Cambodia.
    Boudarene L; James R; Coker R; Khan MS
    Health Policy Plan; 2017 Oct; 32(suppl_2):i3-i11. PubMed ID: 29028223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health policy and systems research agendas in developing countries.
    Gonzalez-Block MA
    Health Res Policy Syst; 2004 Aug; 2(1):6. PubMed ID: 15296509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
    Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
    Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we improve priority-setting for investments in health research? A case study of tuberculosis.
    Khan MS; Rahman-Shepherd A; Painter H; Fletcher H
    Health Res Policy Syst; 2019 Jul; 17(1):68. PubMed ID: 31324187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
    Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
    EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013.
    Head MG; Fitchett JR; Derrick G; Wurie FB; Meldrum J; Kumari N; Beattie B; Counts CJ; Atun R
    Health Res Policy Syst; 2015 Nov; 13():63. PubMed ID: 26537547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The re-emergence of tuberculosis.
    Porter JD; McAdam KP
    Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating tuberculosis research into global policies: the example of an international collaboration on diagnostics.
    Ramsay A; Steingart KR; Cunningham J; Pai M
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1283-93. PubMed ID: 22283885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neglected tropical diseases in Brazil: lack of correlation between disease burden, research funding and output.
    Fonseca BP; Albuquerque PC; Zicker F
    Trop Med Int Health; 2020 Nov; 25(11):1373-1384. PubMed ID: 32860446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
    Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
    EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How research can help control tuberculosis.
    Chaisson RE; Harrington M
    Int J Tuberc Lung Dis; 2009 May; 13(5):558-68. PubMed ID: 19383187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.
    McIntosh SA; Alam F; Adams L; Boon IS; Callaghan J; Conti I; Copson E; Carson V; Davidson M; Fitzgerald H; Gautam A; Jones CM; Kargbo S; Lakshmipathy G; Maguire H; McFerran K; Mirandari A; Moore N; Moore R; Murray A; Newman L; Robinson SD; Segaran A; Soong CN; Walker A; Wijayaweera K; Atun R; Cutress RI; Head MG
    Lancet Oncol; 2023 Jun; 24(6):636-645. PubMed ID: 37269844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting equitable global health research: a policy analysis of the Canadian funding landscape.
    Plamondon K; Walters D; Campbell S; Hatfield J
    Health Res Policy Syst; 2017 Aug; 15(1):72. PubMed ID: 28851388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priority gaps and promising areas in maternal health research in low- and middle-income countries: summary findings of a mapping of 2292 publications between 2000 and 2012.
    Chersich MF; Martin G
    Global Health; 2017 Feb; 13(1):6. PubMed ID: 28153038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.